
    
      This is a Phase 2, Proof of Concept, multicenter, randomized, double-blind,
      placebo-controlled, parallel-group study to evaluate the efficacy and safety of 2 doses of
      GED-0507-34-Levo in subjects with active, mild-to-moderate Ulcerative Colitis.

      The study will consist of 3 phases:

        -  Screening Phase - up to 4 weeks

        -  Double-blind Placebo-controlled Phase - Weeks 0 to 8

        -  Follow-up Phase - Week 9
    
  